Results 11 to 20 of about 401,548 (249)
Frequency of Thrombocytopenia in Malaria and its prognostic significance
Journal of University Medical & Dental College, 2023 BACKGROUND & OBJECTIVE: Thrombocytopenia is a common hematological manifestation of malaria, but locally there is limited data on the association of thrombocytopenia degree and malarial species in Pakistan.
Saleh Ahmad +3 more
doaj +1 more source
British medical journal, 2021 Objective To assess rates of cardiovascular and haemostatic events in the first 28 days after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S in Denmark and Norway and to compare them with rates observed in the general populations.
A. Pottegård +15 more
semanticscholar +1 more source
Global Pediatric Health, 2021 Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis and providing accurate management in rare causes of ...
Mobin Paul MBBS, MD, DM +4 more
doaj +1 more source
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination
American journal of hematology/oncology, 2021 Cases of apparent secondary immune thrombocytopenia (ITP) after SARS-CoV-2 vaccination with both the Pfizer and Moderna versions have been reported and reached public attention.
Eun-Ju Lee +10 more
semanticscholar +1 more source
Platelets, 2022 Thrombocytopenia is common in critical illness. But there are no studies that focus on thrombocytopenia and platelet recovery in Sepsis-3 patients. We employed a large database to identify sepsis based on Sepsis-3 criteria. Patients were grouped by nadir
Hui Zhou +3 more
doaj +1 more source
Annals of Internal Medicine, 2022 Using the Vaccine Adverse Event Reporting System, the number and demographic characteristics of cases of thrombosis with thrombocytopenia syndrome occurring after receipt of COVID-19 vaccines in the United States were determined.
I. See +23 more
semanticscholar +1 more source
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
Blood, 2021 SARS-CoV-2 vaccine ChAdOx1 nCov-19 (AstraZeneca) causes a thromboembolic complication termed vaccine-induced immune thrombotic thrombocytopenia (VITT).
A. Greinacher +30 more
semanticscholar +1 more source
The Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: A Retrospective Cohort Study. [PDF]
PLoS ONE, 2016 Studies on the incidence and risk factors of thrombocytopenia among intra-abdominal infection patients remain absent, hindering efficacy assessments regarding thrombocytopenia prevention strategies.We retrospectively studied 267 consecutively enrolled ...
Qin Wu +9 more
doaj +1 more source
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy [PDF]
, 2016 Preclinical models suggest that histone deacetylase (HDAC) and mammalian target of rapamycin (mTOR) inhibitors have synergistic anticancer activity. We designed a phase I study to determine the safety, maximum tolerated dose (MTD), recommended phase II ...
et al,, Park, Haeseong
core +5 more sources
Thrombocytopenia and clinical outcomes among patients with COVID‐19 disease: A cohort study
Health Science Reports, 2023 Background and Aims Thrombocytopenia is increasingly recognized among patients with critical illness and plays a role in several diseases affecting different organ systems. Therefore, we studied the prevalence of thrombocytopenia among hospitalized COVID‐
Hussain Alkhalifa +4 more
doaj +1 more source